Abstract:OBJECTIVE To evaluate the effect of intravenous immunoglobulin (IVIG) and vitamin C on the progression of experimental autoimmune myocarditis(EAM). METHODS Fifty-two Balb/c mice were randomized into six groups: The blank group received no treatment, the remaining 5 groups were immunized with 100mug emulsified porcine myosin at d 1 and d 7. Different agents were injected from d 1, SVitC group:150 mg/kg*d(-1)vitamin C; LVitC group: 300 mg/kg*d(-1)vitamin C; IVIG group: 1 g/kg*d(-1)IVIG; IVIG+VitC group: 1 g/kg*d(-1)IVIG and 150 mg/kg*d(-1)vitamin C; The control group same volume of normal saline. All mice were sacrificed at d 21, and serum TNF-alpha levels were detected with enzyme linked immunosorbent assay (ELISA). The ratio of heart to body weight(C/W), spleen to body weight(S/W) and kidney to body weigh(R/W) were calculated. The spleens and heart were examined pathologically and/or immunohistochemically. RESULT Compared with those of control group, inflammatory cells infiltration in the myocardium and calcification in the pericardiume in SVitC and LVitC groups were extenuated. There were inflammatory cells infiltrating in the myocardium sparely and no calcification in the pericardium in IVIG and IVIG+VitC groups. The size of spleens enlarged especially in IVIG and IVIG+VitC groups. White and red pulps of spleens were hyperplastic microscopically. The C/W of treatment groups decreased significantly compared with that of control group. The S/W of therapy groups and control group was significantly higher than that of blank group; and the S/W of IVIG and IVIG + VitC groups was significantly higher than that of SVitC and LVitC groups. The R/W in each groups had no significant difference. The TNF-alpha level in SVitC and LVitC groups was a little lower than that in control group; TNF-alpha level in IVIG and IVIG+VitC groups was significantly lower than that of control group. Wide fluorescence stripe was found along extracellular matrix surrounding the damaged cardiomyocytes of control group. Both density and intensity of fluorescence in SVitC and LVitC groups were lower than those of control group. There were much wider fluorescence stripe and strengthened intensity in IVIG and IVIG + VitC groups. The myofilaments were in wild disorder and sarcomere had severe breakage in control group. Moreover, chondriosome hypertrophy and vacuolar degeneration were found. The damage lessened in SVitC and LVitC groups. Both myofilaments and sarcomeres in IVIG and IVIG + VitC groups were almost normal, and the chondriosome was normal. CONCLUSION IVIG and vitamin C have some protective and therapeutic effect on the progression of EAM by decreasing pathological damage of myocardium and depressing TNF-alpha production, and IVIG combined with vitamin C is more effective.

Experimental autoimmune myositis model induced by pure myosin of rabbit

Establishment of Animal Models of Experimental Autoimmune Myositis

Establishment of the animal model of experimental autoimmune myositis

Development of an improved animal model of experimental autoimmune myositis.

Establishment of a Mouse Model of Experimental Autoimmune Myasthenia Gravis

[Effect of Intravenous Immunoglobulin and Vitamin C on Progression of Experimental Autoimmune Myocarditis in Mice].

Expression and significance of gene mRNA of urokinase type plasminogen activator and its inhibitor 1 type in muscle of exprimental autoimmune myositis guinea pigs

Expression and significance of 4-1BB/4-1BBL in experimental autoimmune myocarditis

Experimental myositis: an optimised version of C-protein-induced myositis

[An Improved Animal Model of Autoimmune Inner Ear Disease].

Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats

AEB-071 Ameliorates Muscle Weakness by Altering Helper T Lymphocytes in an Experimental Autoimmune Myasthenia Gravis Rat Model

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

[Establishment of human cardiac C protein induced experimental autoimmune myocarditis model in rat]

Suppression of Experimental Autoimmune Myasthenia Gravis by Nasal Administration of Acetylcholine Receptor

Mice with IFN-gamma Receptor Deficiency Are Less Susceptible to Experimental Autoimmune Myasthenia Gravis.

Murine models of idiopathic inflammatory myopathy

Effect of Cathepsin B Inhibitor CA-074Me on the Model of Mice Viral Myocarditis

Active immunization of combined beta1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits

A new mouse model of autoimmune ocular myasthenia gravis.